McKesson Corporation Common Stock (NYSE: MCK)
Plaintiff’s law firm issued a press release on October 25, 2018, announcing the filing of the lawsuit. According to the press release, McKesson delivers pharmaceutical and medical products and business services to retail pharmacies and institutional healthcare providers such as hospitals and health systems throughout North America and internationally. The majority of its income is derived from its business as a pharmaceutical wholesaler in which it purchases drugs in bulk directly from manufacturers and then sells and distributes those drugs to pharmacy networks, hospitals, and independent pharmacies.